Antibiotic Microbiome & Mucosal Stewardship Protocol
Physician-built antibiotic companion combining antibiotic-proof Saccharomyces boulardii CNCM I-745 (10B CFU), endospore Bacillus strains, and L-Glutamine mucosal fuel.
Enlarge1/2 ViewsAntibiotic Microbiome & Mucosal Stewardship Protocol (Saccharomyces Boulardii CNCM I-745 + Spore Bacillus + L-Glutamine)
Antibiotic Microbiome Stewardship: High-potency Lactobacillus & Bifidobacterium protocol (dosed 2 hours apart from antibiotics) to prevent antibiotic-associated dysbiosis.
- Antibiotic-associated gastroenteritis and colitis
- Clostridioides difficile prophylaxis
- Post-infectious irritable bowel syndrome
AGA Clinical Practice Guidelines on Probiotics in GI Disorders — Saccharomyces boulardii CNCM I-745 is conditionally recommended for prevention of C. difficile and antibiotic-associated diarrhea.
Sync your health records or ask Healix Medical Intelligence by voice on this page.
Product Details & Clinical Specifications — Antibiotic Microbiome & Mucosal Stewardship Protocol
Antibiotic Microbiome & Mucosal Stewardship Protocol from HealixAI is physician-built antibiotic companion combining antibiotic-proof Saccharomyces boulardii CNCM I-745 (10B CFU), endospore Bacillus strains, and L-Glutamine mucosal fuel.

- Active Ingredients & Clinical Formulation: Antibiotic Microbiome & Mucosal Stewardship Protocol (Saccharomyces Boulardii CNCM I-745 + Spore Bacillus + L-Glutamine) (Clinical Supplement, HCPCS/Code LMN-213D).
- Clinical Guideline & Mechanism: AGA Clinical Practice Guidelines on Probiotics in GI Disorders — Saccharomyces boulardii CNCM I-745 is conditionally recommended for prevention of C. difficile and antibiotic-associated diarrhea.
- HSA/FSA Pre-Tax Eligibility: Qualifies for ~30% pre-tax HSA/FSA savings ($36.40 effective pre-tax vs $52.00 retail) via an instant IRS § 213(d) Letter of Medical Necessity (LMN) issued by HealixAI.
- Qualifying ICD-10-CM Indications: Antibiotic-associated gastroenteritis and colitis (K52.9), Clostridioides difficile prophylaxis (A04.72), Post-infectious irritable bowel syndrome (K58.0).
- Live Specialty Voice AI Consultation: Includes 24kHz real-time WebRTC clinical voice consultation with Miller (Gastroenterology & Microbiome Voice Intelligence) for personalized dosing, sizing, and medication interaction checks.
